BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE was reported 97871 times

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REVERSIBLE AIRWAYS OBSTRUCTION 200 0.3937
1 CONGENITAL HIATUS HERNIA 88 0.3860
2 INTENTIONAL DEVICE MISUSE 1305 0.2957
3 TOTAL LUNG CAPACITY INCREASED 74 0.2721
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 118 0.2256
5 VITAL CAPACITY DECREASED 99 0.2210
6 FORCED EXPIRATORY VOLUME DECREASED 581 0.2049
7 RESPIRATORY GAS EXCHANGE DISORDER 70 0.1887
8 FORCED VITAL CAPACITY DECREASED 120 0.1838
9 OBSTRUCTIVE AIRWAYS DISORDER 1978 0.1776
10 EOSINOPHIL COUNT ABNORMAL 126 0.1687
11 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 151 0.1629
12 LARYNGEAL STENOSIS 89 0.1540
13 VOCAL CORD DYSFUNCTION 75 0.1521
14 BLOOD IMMUNOGLOBULIN E INCREASED 365 0.1506
15 RESPIRATORY TRACT INFLAMMATION 70 0.1502
16 PEAK EXPIRATORY FLOW RATE DECREASED 65 0.1477
17 BRONCHIAL WALL THICKENING 95 0.1321
18 DEVICE MISUSE 168 0.1271
19 LUNG HYPERINFLATION 106 0.1233
20 ASTHMATIC CRISIS 449 0.1228
21 DRUG DELIVERY SYSTEM ISSUE 230 0.1165
22 FULL BLOOD COUNT ABNORMAL 1205 0.1138
23 ASTHMA 12227 0.1081
24 ALLERGY TO ANIMAL 112 0.1051
25 PERFUME SENSITIVITY 59 0.1037
26 SPUTUM DISCOLOURED 967 0.1019
27 DUST ALLERGY 99 0.1009
28 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1698 0.0999
29 OFF LABEL USE OF DEVICE 135 0.0998
30 TOTAL LUNG CAPACITY DECREASED 159 0.0995
31 WHEEZING 5768 0.0972
32 BREATH SOUNDS ABNORMAL 478 0.0968
33 PULMONARY FUNCTION TEST ABNORMAL 145 0.0930
34 SENSITISATION 69 0.0909
35 PULMONARY FUNCTION TEST DECREASED 393 0.0897
36 BRONCHIAL SECRETION RETENTION 109 0.0856
37 BRONCHIECTASIS 556 0.0824
38 NASAL POLYPS 400 0.0812
39 RESTRICTIVE PULMONARY DISEASE 94 0.0802
40 RHONCHI 108 0.0781
41 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4067 0.0779
42 BRONCHIAL HYPERREACTIVITY 93 0.0773
43 SPUTUM RETENTION 76 0.0767
44 BRONCHIAL DISORDER 119 0.0765
45 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 151 0.0740
46 NASAL DISCHARGE DISCOLOURATION 101 0.0732
47 MYCOTIC ALLERGY 62 0.0725
48 LOWER RESPIRATORY TRACT CONGESTION 123 0.0723
49 BLOOD COUNT ABNORMAL 1086 0.0716
50 NASAL OBSTRUCTION 134 0.0714
51 INTENTIONAL DEVICE USE ISSUE 61 0.0713
52 DEVICE INEFFECTIVE 76 0.0710
53 DEVICE USE ISSUE 1206 0.0689
54 EOSINOPHIL COUNT INCREASED 562 0.0674
55 RHINITIS ALLERGIC 297 0.0667
56 EMPHYSEMA 654 0.0648
57 LIP INJURY 84 0.0641
58 CHRONIC SINUSITIS 240 0.0639
59 NOCTURNAL DYSPNOEA 81 0.0635
60 BRONCHITIS CHRONIC 151 0.0618
61 UPPER-AIRWAY COUGH SYNDROME 490 0.0594
62 OBSTRUCTIVE SLEEP APNOEA SYNDROME 85 0.0583
63 PRODUCTIVE COUGH 2730 0.0571
64 BODY HEIGHT DECREASED 610 0.0570
65 BRONCHIAL OBSTRUCTION 75 0.0534
66 HYPOVENTILATION 170 0.0521
67 DEVICE DELIVERY SYSTEM ISSUE 1420 0.0518
68 SPUTUM INCREASED 112 0.0517
69 VOCAL CORD DISORDER 102 0.0516
70 THROAT CLEARING 186 0.0496
71 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2351 0.0489
72 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 262 0.0481
73 DEVICE FAILURE 731 0.0480
74 MALIGNANT MELANOMA IN SITU 59 0.0476
75 MULTIPLE ALLERGIES 372 0.0474
76 POLYCYSTIC OVARIES 73 0.0470
77 ESSENTIAL HYPERTENSION 84 0.0459
78 RALES 266 0.0458
79 SINUS PAIN 106 0.0454
80 INCREASED BRONCHIAL SECRETION 115 0.0449
81 SECRETION DISCHARGE 552 0.0440
82 DYSPNOEA AT REST 126 0.0434
83 RESPIRATORY SYMPTOM 122 0.0429
84 DYSPNOEA EXERTIONAL 1611 0.0427
85 SENSITIVITY TO WEATHER CHANGE 225 0.0427
86 LUNG OPACITY 112 0.0425
87 SEASONAL ALLERGY 601 0.0424
88 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2978 0.0418
89 INTENTIONAL PRODUCT MISUSE 3558 0.0406
90 DEVICE MALFUNCTION 2806 0.0399
91 APHONIA 550 0.0394
92 RHINITIS 315 0.0390
93 INCREASED UPPER AIRWAY SECRETION 200 0.0389
94 RESPIRATION ABNORMAL 264 0.0383
95 TERMINAL INSOMNIA 66 0.0372
96 RESPIRATORY TRACT CONGESTION 588 0.0370
97 MIDDLE INSOMNIA 691 0.0370
98 DYSPHONIA 2102 0.0359
99 PULMONARY CONGESTION 471 0.0357
100 INFUSION SITE BRUISING 77 0.0356
101 KYPHOSIS 62 0.0350
102 SLEEP APNOEA SYNDROME 667 0.0349
103 OXYGEN SATURATION ABNORMAL 99 0.0348
104 PULMONARY MASS 490 0.0329
105 SNORING 124 0.0328
106 REBOUND ACID HYPERSECRETION 99 0.0327
107 NASAL DISORDER 87 0.0327
108 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1523 0.0326
109 MYCOBACTERIAL INFECTION 56 0.0325
110 NASAL SEPTUM DEVIATION 63 0.0322
111 BRONCHITIS 2372 0.0320
112 BODY TEMPERATURE DECREASED 315 0.0320
113 CYSTIC FIBROSIS 177 0.0319
114 CANDIDA INFECTION 536 0.0317
115 DYSPNOEA 17904 0.0316
116 INCORRECT DOSE ADMINISTERED BY DEVICE 819 0.0312
117 LUNG INFECTION 474 0.0305
118 CHEST DISCOMFORT 3084 0.0301
119 PNEUMONIA VIRAL 96 0.0301
120 BRONCHOSPASM 429 0.0300
121 LUNG CONSOLIDATION 84 0.0300
122 PULMONARY PAIN 87 0.0298
123 LUNG DISORDER 1443 0.0294
124 CHEST X-RAY ABNORMAL 90 0.0293
125 NEPHROGENIC ANAEMIA 135 0.0291
126 ORAL CANDIDIASIS 380 0.0288
127 BLOOD PRESSURE SYSTOLIC INCREASED 562 0.0288
128 COUGH 8045 0.0287
129 UPPER RESPIRATORY TRACT CONGESTION 83 0.0286
130 RESPIRATORY DISORDER 854 0.0285
131 SINUS DISORDER 560 0.0282
132 BENIGN PROSTATIC HYPERPLASIA 146 0.0282
133 CREPITATIONS 84 0.0282
134 INFUSION SITE HAEMORRHAGE 92 0.0279
135 RESPIRATORY TRACT INFECTION 728 0.0279
136 RESPIRATORY RATE INCREASED 248 0.0279
137 EOSINOPHILIA 489 0.0279
138 SINUS CONGESTION 369 0.0273
139 NASAL CONGESTION 1589 0.0270
140 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 64 0.0269
141 LOWER RESPIRATORY TRACT INFECTION 1224 0.0269
142 HYPERPARATHYROIDISM SECONDARY 67 0.0267
143 PARANASAL SINUS DISCOMFORT 100 0.0264
144 OBSTRUCTION 105 0.0263
145 SUFFOCATION FEELING 65 0.0262
146 RESPIRATORY TRACT INFECTION VIRAL 61 0.0262
147 MYCOBACTERIUM AVIUM COMPLEX INFECTION 70 0.0261
148 BLOOD TEST ABNORMAL 366 0.0260
149 INFUSION SITE PRURITUS 80 0.0253
150 POLYP 165 0.0252
151 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 822 0.0243
152 DRY THROAT 247 0.0243
153 DEVICE DEFECTIVE 414 0.0239
154 ORAL FUNGAL INFECTION 64 0.0234
155 PRODUCT TASTE ABNORMAL 316 0.0233
156 HAEMOPTYSIS 634 0.0227
157 DRUG DELIVERY SYSTEM MALFUNCTION 116 0.0227
158 INSURANCE ISSUE 343 0.0224
159 THROAT IRRITATION 1000 0.0223
160 IMPAIRED QUALITY OF LIFE 320 0.0222
161 GRANULOMA 77 0.0222
162 INFUSION SITE SWELLING 139 0.0221
163 DRUG DOSE OMISSION 3643 0.0220
164 INTENTIONAL DRUG MISUSE 459 0.0219
165 SARCOIDOSIS 104 0.0219
166 BRONCHIOLITIS 77 0.0219
167 DECREASED ACTIVITY 236 0.0219
168 SINUSITIS 2239 0.0218
169 OROPHARYNGEAL DISCOMFORT 196 0.0217
170 GLOSSITIS 77 0.0217
171 OXYGEN SATURATION DECREASED 1203 0.0214
172 EAR PRURITUS 74 0.0211
173 CANDIDIASIS 84 0.0209
174 UPPER RESPIRATORY TRACT INFECTION 962 0.0208
175 ORTHOPNOEA 66 0.0207
176 PROSTATOMEGALY 81 0.0206
177 INABILITY TO AFFORD MEDICATION 203 0.0204
178 GASTROOESOPHAGEAL REFLUX DISEASE 1637 0.0203
179 CHOKING SENSATION 111 0.0201
180 TONGUE DISCOLOURATION 88 0.0201
181 EXERCISE TOLERANCE DECREASED 114 0.0198
182 OROPHARYNGEAL PAIN 1817 0.0196
183 OVERWEIGHT 105 0.0195
184 HYPERVENTILATION 110 0.0190
185 FRUSTRATION TOLERANCE DECREASED 151 0.0187
186 INFUSION SITE ERYTHEMA 156 0.0185
187 CHOKING 361 0.0185
188 PNEUMONIA 5945 0.0183
189 POLYMYALGIA RHEUMATICA 58 0.0182
190 HIATUS HERNIA 236 0.0182
191 RESPIRATORY RATE DECREASED 57 0.0181
192 RHINORRHOEA 1173 0.0181
193 PRE-EXISTING CONDITION IMPROVED 113 0.0181
194 OESOPHAGEAL CANDIDIASIS 72 0.0180
195 HEARING IMPAIRED 108 0.0180
196 HYPOPNOEA 62 0.0178
197 GLAUCOMA 343 0.0178
198 ATELECTASIS 171 0.0177
199 VIRAL UPPER RESPIRATORY TRACT INFECTION 84 0.0177
200 SNEEZING 393 0.0175
201 APPARENT DEATH 63 0.0175
202 BLOOD PRESSURE DIASTOLIC INCREASED 80 0.0173
203 DEVICE ISSUE 1542 0.0172
204 WEIGHT FLUCTUATION 179 0.0171
205 FOOD ALLERGY 132 0.0171
206 BLOOD CHOLESTEROL ABNORMAL 79 0.0171
207 RED CELL DISTRIBUTION WIDTH INCREASED 71 0.0171
208 VIRAL INFECTION 566 0.0170
209 PHARYNGITIS 209 0.0168
210 RESPIRATORY SYNCYTIAL VIRUS INFECTION 143 0.0164
211 MACULAR DEGENERATION 194 0.0162
212 IRON DEFICIENCY 73 0.0162
213 CATARACT 966 0.0162
214 INFLUENZA 1777 0.0159
215 SENSATION OF FOREIGN BODY 134 0.0159
216 INFUSION SITE PAIN 203 0.0157
217 PNEUMOTHORAX 247 0.0156
218 CARPAL TUNNEL SYNDROME 218 0.0156
219 TONGUE DISCOMFORT 66 0.0155
220 GLUCOSE TOLERANCE IMPAIRED 91 0.0154
221 NASOPHARYNGITIS 2836 0.0154
222 GOITRE 63 0.0154
223 NEUTROPHIL COUNT INCREASED 156 0.0152
224 RHINOVIRUS INFECTION 59 0.0151
225 OESOPHAGEAL DISORDER 58 0.0150
226 PRODUCT DOSE OMISSION 972 0.0149
227 PULMONARY FIBROSIS 284 0.0148
228 BLOOD PRESSURE DIASTOLIC DECREASED 109 0.0148
229 OSTEOPOROSIS 607 0.0147
230 RIB FRACTURE 303 0.0147
231 FEELING JITTERY 280 0.0147
232 VASCULITIS 171 0.0147
233 PULMONARY THROMBOSIS 160 0.0147
234 ASPHYXIA 119 0.0146
235 ABNORMAL LOSS OF WEIGHT 99 0.0145
236 RENAL CYST 115 0.0145
237 EAR INFECTION 385 0.0145
238 UMBILICAL HERNIA 67 0.0143
239 CARDIAC MURMUR 124 0.0143
240 PHARYNGEAL SWELLING 140 0.0143
241 VITAMIN D DEFICIENCY 139 0.0142
242 EAR DISCOMFORT 146 0.0142
243 BUNDLE BRANCH BLOCK LEFT 60 0.0141
244 LUNG NEOPLASM MALIGNANT 580 0.0141
245 CARDIAC FAILURE CHRONIC 60 0.0141
246 MUSCULOSKELETAL CHEST PAIN 215 0.0139
247 INCORRECT DRUG ADMINISTRATION RATE 59 0.0138
248 HEART RATE INCREASED 1361 0.0137
249 HYPOXIA 482 0.0137
250 PHARYNGITIS STREPTOCOCCAL 148 0.0137
251 PNEUMONIA BACTERIAL 123 0.0134
252 TOOTH ABSCESS 136 0.0133
253 BACTERIAL INFECTION 249 0.0133
254 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86 0.0132
255 THROAT TIGHTNESS 358 0.0132
256 JOINT INJURY 281 0.0131
257 EAR DISORDER 60 0.0131
258 PRODUCT QUALITY ISSUE 1753 0.0129
259 PANIC REACTION 93 0.0129
260 HYPERCHOLESTEROLAEMIA 124 0.0128
261 BLOOD IRON DECREASED 152 0.0128
262 SKIN ABRASION 60 0.0127
263 ANEURYSM 63 0.0126
264 SINUS HEADACHE 75 0.0126
265 NASAL DISCOMFORT 100 0.0126
266 TONGUE DISORDER 91 0.0126
267 EYE DISORDER 412 0.0125
268 SKIN ATROPHY 72 0.0125
269 PLEURISY 74 0.0124
270 ANKLE FRACTURE 192 0.0124
271 GASTROENTERITIS VIRAL 221 0.0122
272 LIGAMENT SPRAIN 121 0.0122
273 NERVOUSNESS 639 0.0122
274 FIBROMYALGIA 297 0.0122
275 CONCUSSION 94 0.0121
276 PRODUCT USE ISSUE 2274 0.0121
277 ORAL DISCOMFORT 168 0.0121
278 ASPIRATION 132 0.0120
279 ASPERGILLUS INFECTION 79 0.0120
280 SCOLIOSIS 74 0.0119
281 OSTEOPENIA 181 0.0119
282 CHRONIC KIDNEY DISEASE 906 0.0119
283 MICTURITION URGENCY 136 0.0119
284 SYMPTOM RECURRENCE 71 0.0119
285 OBESITY 188 0.0118
286 BLOOD PRESSURE ABNORMAL 234 0.0118
287 BLOOD PRESSURE INCREASED 1798 0.0117
288 ORAL PAIN 263 0.0117
289 INCREASED TENDENCY TO BRUISE 108 0.0117
290 INFUSION SITE EXTRAVASATION 73 0.0117
291 HYPOACUSIS 503 0.0117
292 INTERVERTEBRAL DISC DEGENERATION 108 0.0117
293 SLEEP DISORDER 823 0.0116
294 LIMB INJURY 316 0.0116
295 ORAL DISORDER 85 0.0116
296 HEART RATE IRREGULAR 262 0.0116
297 BLOOD LACTIC ACID INCREASED 61 0.0116
298 EYE PRURITUS 389 0.0116
299 LACRIMATION INCREASED 349 0.0115
300 RESPIRATORY DISTRESS 318 0.0115
301 PHARYNGEAL OEDEMA 177 0.0115
302 HYPERLIPIDAEMIA 137 0.0115
303 AFFECTIVE DISORDER 90 0.0114
304 AORTIC ANEURYSM 87 0.0114
305 UPPER LIMB FRACTURE 227 0.0114
306 ACUTE RESPIRATORY FAILURE 219 0.0114
307 ILLNESS 1172 0.0114
308 FOOT FRACTURE 215 0.0113
309 IMMUNE SYSTEM DISORDER 149 0.0113
310 CHEST PAIN 2085 0.0112
311 END STAGE RENAL DISEASE 205 0.0112
312 SKIN LACERATION 122 0.0112
313 PRODUCT ADMINISTRATION INTERRUPTED 88 0.0112
314 PSEUDOMONAS INFECTION 96 0.0112
315 ANOSMIA 162 0.0112
316 TRANSIENT ISCHAEMIC ATTACK 377 0.0112
317 DIABETES MELLITUS 851 0.0112
318 SPINAL OSTEOARTHRITIS 98 0.0111
319 RIGHT VENTRICULAR FAILURE 78 0.0111
320 MUSCULOSKELETAL DISCOMFORT 191 0.0111
321 KIDNEY INFECTION 216 0.0110
322 ADRENAL INSUFFICIENCY 133 0.0109
323 BACK DISORDER 178 0.0109
324 ARTHROPOD BITE 81 0.0109
325 SWOLLEN TONGUE 340 0.0109
326 PULMONARY HYPERTENSION 226 0.0108
327 COVID-19 PNEUMONIA 128 0.0108
328 ARTHRITIS 852 0.0108
329 ACCIDENT 128 0.0107
330 GOUT 192 0.0107
331 DIVERTICULITIS 296 0.0107
332 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 94 0.0106
333 BLOOD PRESSURE FLUCTUATION 255 0.0106
334 MALAISE 4658 0.0106
335 BACK INJURY 115 0.0106
336 ARTERIOSCLEROSIS CORONARY ARTERY 70 0.0106
337 SUPRAVENTRICULAR TACHYCARDIA 101 0.0105
338 PROSTATIC DISORDER 58 0.0105
339 WRIST FRACTURE 126 0.0105
340 ECCHYMOSIS 72 0.0105
341 TENDON RUPTURE 129 0.0104
342 LOWER GASTROINTESTINAL HAEMORRHAGE 77 0.0104
343 DIVERTICULUM 74 0.0104
344 HYPOTHYROIDISM 332 0.0104
345 EAR PAIN 202 0.0104
346 WEIGHT DECREASED 2900 0.0104
347 BLOOD CALCIUM INCREASED 91 0.0104
348 HYPERTENSION 2195 0.0104
349 EYE INFECTION 117 0.0104
350 PRODUCT DOSE OMISSION ISSUE 3010 0.0102
351 TYPE 2 DIABETES MELLITUS 344 0.0102
352 NERVE COMPRESSION 94 0.0102
353 GENERAL PHYSICAL CONDITION ABNORMAL 69 0.0102
354 MUSCLE STRAIN 88 0.0102
355 ANGIOPATHY 57 0.0102
356 DRY MOUTH 821 0.0101
357 TOOTH INFECTION 133 0.0101
358 HERNIA 195 0.0101
359 WEIGHT INCREASED 2256 0.0101
360 NASAL DRYNESS 63 0.0100
361 LOCALISED INFECTION 243 0.0100
362 FUNGAL INFECTION 334 0.0100
363 TENDONITIS 155 0.0100
364 CARDIAC VALVE DISEASE 57 0.0100
365 TENDON DISORDER 65 0.0100
366 BLOOD MAGNESIUM DECREASED 86 0.0100
367 RETCHING 212 0.0099
368 PULMONARY ARTERIAL HYPERTENSION 144 0.0099
369 VISUAL IMPAIRMENT 1231 0.0099
370 OSTEOARTHRITIS 421 0.0099
371 THYROID DISORDER 153 0.0099
372 ATRIAL FIBRILLATION 966 0.0099
373 CONTUSION 952 0.0099
374 HYPERSENSITIVITY 1828 0.0098
375 ANAPHYLACTIC REACTION 544 0.0098
376 ARTERIAL OCCLUSIVE DISEASE 77 0.0098
377 BLOOD POTASSIUM DECREASED 294 0.0098
378 TENDON PAIN 74 0.0098
379 OEDEMA PERIPHERAL 1188 0.0097
380 ECZEMA 510 0.0097
381 CELLULITIS 490 0.0097
382 BIPOLAR DISORDER 105 0.0096
383 PARAESTHESIA ORAL 139 0.0096
384 LIP SWELLING 319 0.0096
385 HEAD DISCOMFORT 169 0.0095
386 CARDIAC DISORDER 890 0.0095
387 AGEUSIA 237 0.0095
388 OCULAR DISCOMFORT 106 0.0094
389 PANIC ATTACK 344 0.0094
390 PAROSMIA 71 0.0094
391 LIMB DISCOMFORT 291 0.0094
392 BURSITIS 114 0.0094
393 INGUINAL HERNIA 57 0.0094
394 CARDIAC FAILURE CONGESTIVE 749 0.0093
395 DERMATITIS CONTACT 106 0.0093
396 HAEMATOMA 239 0.0092
397 TEMPERATURE INTOLERANCE 95 0.0092
398 POOR QUALITY SLEEP 198 0.0092
399 HAND FRACTURE 65 0.0092
400 NEURALGIA 223 0.0092
401 GASTROINTESTINAL INFECTION 82 0.0091
402 PLATELET COUNT INCREASED 119 0.0091
403 INTERVERTEBRAL DISC PROTRUSION 198 0.0090
404 STENT PLACEMENT 73 0.0090
405 SPINAL FRACTURE 181 0.0090
406 VITAMIN D DECREASED 77 0.0090
407 CYSTITIS 286 0.0090
408 CARDIAC FLUTTER 58 0.0090
409 ROTATOR CUFF SYNDROME 115 0.0089
410 MEMORY IMPAIRMENT 1230 0.0089
411 SKIN LESION 245 0.0089
412 TREMOR 1482 0.0089
413 ARTERIOSCLEROSIS 84 0.0089
414 SKIN PLAQUE 75 0.0089
415 POST PROCEDURAL INFECTION 72 0.0088
416 MASS 123 0.0088
417 PULMONARY OEDEMA 394 0.0088
418 VISUAL ACUITY REDUCED 292 0.0088
419 MUSCLE SPASMS 1610 0.0088
420 RESPIRATORY FAILURE 638 0.0087
421 HEART RATE DECREASED 307 0.0087
422 FACIAL PAIN 78 0.0087
423 ORAL HERPES 170 0.0087
424 HERPES ZOSTER 500 0.0087
425 PRESYNCOPE 211 0.0087
426 PNEUMONITIS 236 0.0087
427 QUALITY OF LIFE DECREASED 116 0.0086
428 SPEECH DISORDER 453 0.0086
429 LYMPHADENOPATHY 306 0.0086
430 BREAST MASS 58 0.0086
431 CORONARY ARTERY OCCLUSION 118 0.0086
432 MUSCULOSKELETAL PAIN 450 0.0086
433 DERMATITIS ALLERGIC 108 0.0086
434 DRUG DOSE OMISSION BY DEVICE 672 0.0086
435 NEPHROPATHY 80 0.0086
436 PALPITATIONS 1003 0.0086
437 POST-TRAUMATIC STRESS DISORDER 57 0.0085
438 BLOOD PRESSURE DECREASED 565 0.0085
439 FEEDING DISORDER 172 0.0085
440 SARS-COV-2 TEST POSITIVE 112 0.0085
441 FEELING ABNORMAL 2030 0.0085
442 JOINT DISLOCATION 89 0.0084
443 TROPONIN INCREASED 64 0.0084
444 COVID-19 1472 0.0084
445 HEREDITARY ANGIOEDEMA 90 0.0084
446 PERIPHERAL SWELLING 1291 0.0084
447 EYE SWELLING 311 0.0084
448 SPINAL COMPRESSION FRACTURE 69 0.0083
449 SCIATICA 133 0.0083
450 BONE DISORDER 152 0.0083
451 GLOSSODYNIA 186 0.0083
452 POSTOPERATIVE WOUND INFECTION 56 0.0083
453 BACK PAIN 1924 0.0083
454 PRODUCT LABEL ISSUE 56 0.0082
455 HIP FRACTURE 265 0.0082
456 GROIN PAIN 72 0.0082
457 CORONARY ARTERY DISEASE 248 0.0082
458 BLOOD SODIUM DECREASED 154 0.0082
459 BLOOD CHOLESTEROL INCREASED 380 0.0081
460 FLUID RETENTION 414 0.0081
461 PRODUCT DISTRIBUTION ISSUE 75 0.0081
462 DYSPEPSIA 793 0.0081
463 ILL-DEFINED DISORDER 489 0.0080
464 SPINAL DISORDER 76 0.0080
465 SKIN INFECTION 90 0.0080
466 DYSGEUSIA 596 0.0080
467 POOR VENOUS ACCESS 83 0.0080
468 ATRIAL FLUTTER 64 0.0080
469 GASTRITIS 210 0.0080
470 NECK PAIN 446 0.0080
471 HYSTERECTOMY 69 0.0080
472 OEDEMA 431 0.0079
473 DISCOMFORT 484 0.0079
474 IMPAIRED GASTRIC EMPTYING 108 0.0079
475 EPISTAXIS 589 0.0079
476 INTENTIONAL PRODUCT USE ISSUE 687 0.0078
477 BODY TEMPERATURE INCREASED 160 0.0078
478 IRRITABLE BOWEL SYNDROME 168 0.0078
479 FALL 2603 0.0078
480 PRODUCT ADMINISTRATION ERROR 158 0.0078
481 HEAD INJURY 247 0.0078
482 SCAB 89 0.0078
483 CONJUNCTIVITIS 144 0.0078
484 MIGRAINE 739 0.0077
485 INSOMNIA 2059 0.0077
486 ROAD TRAFFIC ACCIDENT 323 0.0077
487 PRODUCT DOSE OMISSION IN ERROR 218 0.0077
488 IRON DEFICIENCY ANAEMIA 71 0.0077
489 POOR QUALITY DEVICE USED 77 0.0077
490 PULMONARY HAEMORRHAGE 60 0.0077
491 GINGIVAL PAIN 61 0.0077
492 HYPOKINESIA 111 0.0076
493 CARDIOMEGALY 94 0.0076
494 INFECTION 1106 0.0076
495 ATRIOVENTRICULAR BLOCK 59 0.0076
496 ANXIETY 2170 0.0076
497 URTICARIA 1274 0.0076
498 POST PROCEDURAL COMPLICATION 146 0.0076
499 PLEURAL EFFUSION 461 0.0076
500 SWELLING FACE 493 0.0076
501 BLADDER DISORDER 75 0.0075
502 GAIT DISTURBANCE 1444 0.0075
503 MUSCLE DISORDER 61 0.0075
504 THERAPY CHANGE 74 0.0075
505 DENTAL CARIES 83 0.0075
506 FACE OEDEMA 126 0.0075
507 URINARY INCONTINENCE 221 0.0075
508 TASTE DISORDER 151 0.0074
509 PERICARDIAL EFFUSION 172 0.0074
510 HEADACHE 4655 0.0074
511 ACTIVITIES OF DAILY LIVING IMPAIRED 147 0.0074
512 CONDITION AGGRAVATED 2255 0.0074
513 CHOLELITHIASIS 243 0.0074
514 STAPHYLOCOCCAL INFECTION 244 0.0074
515 BLINDNESS UNILATERAL 104 0.0074
516 CHILLS 862 0.0073
517 LOWER LIMB FRACTURE 140 0.0073
518 RESTLESS LEGS SYNDROME 132 0.0073
519 TOOTHACHE 131 0.0072
520 HYPERSOMNIA 207 0.0072
521 VISION BLURRED 991 0.0072
522 DEMENTIA 201 0.0072
523 PELVIC FRACTURE 56 0.0072
524 ANGINA PECTORIS 206 0.0072
525 DRUG EFFECT LESS THAN EXPECTED 106 0.0071
526 LUNG INFILTRATION 63 0.0071
527 TACHYCARDIA 633 0.0071
528 DIZZINESS POSTURAL 69 0.0071
529 IMMUNODEFICIENCY 106 0.0071
530 RENAL FAILURE 944 0.0071
531 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1281 0.0071
532 DYSURIA 261 0.0071
533 CHOLECYSTECTOMY 81 0.0071
534 CYST 88 0.0071
535 HEPATIC STEATOSIS 132 0.0071
536 THIRST 126 0.0070
537 PRODUCT PACKAGING ISSUE 67 0.0070
538 FATIGUE 5483 0.0070
539 FLANK PAIN 66 0.0070
540 EYE PAIN 395 0.0070
541 ASTHENIA 2624 0.0070
542 ACUTE KIDNEY INJURY 1065 0.0070
543 DRY EYE 347 0.0069
544 GENERALISED OEDEMA 86 0.0069
545 WHITE BLOOD CELL COUNT INCREASED 266 0.0069
546 CYANOSIS 109 0.0069
547 NERVE INJURY 77 0.0069
548 SCRATCH 73 0.0069
549 INTERNAL HAEMORRHAGE 79 0.0069
550 BLOOD URINE PRESENT 131 0.0069
551 BRAIN INJURY 69 0.0069
552 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1389 0.0068
553 RENAL DISORDER 319 0.0068
554 RENAL TUBULAR NECROSIS 67 0.0068
555 CLOSTRIDIUM DIFFICILE INFECTION 149 0.0068
556 OFF LABEL USE 5977 0.0068
557 NEPHROLITHIASIS 313 0.0068
558 RECTAL HAEMORRHAGE 292 0.0068
559 INFLAMMATION 350 0.0068
560 FAECES DISCOLOURED 147 0.0068
561 GASTRIC DISORDER 232 0.0068
562 URINARY TRACT INFECTION 1153 0.0068
563 ARRHYTHMIA 320 0.0068
564 PAIN IN EXTREMITY 1988 0.0067
565 DIZZINESS 3365 0.0067
566 VERTIGO 411 0.0067
567 FLUID OVERLOAD 98 0.0067
568 PULMONARY EMBOLISM 637 0.0067
569 LEUKAEMIA 63 0.0067
570 DRUG DISPENSING ERROR 102 0.0067
571 NOCTURIA 81 0.0067
572 AUTOIMMUNE DISORDER 65 0.0067
573 CARDIAC FAILURE 535 0.0067
574 INTENTIONAL DOSE OMISSION 189 0.0066
575 HAEMORRHOIDS 129 0.0066
576 NIGHT SWEATS 213 0.0066
577 AMNESIA 430 0.0066
578 MYALGIA 1122 0.0066
579 MYOCARDIAL ISCHAEMIA 75 0.0066
580 NIGHTMARE 228 0.0066
581 EXOSTOSIS 60 0.0066
582 SWELLING 614 0.0066
583 PYREXIA 2269 0.0066
584 PURPURA 58 0.0065
585 VENTRICULAR EXTRASYSTOLES 68 0.0065
586 DEAFNESS 171 0.0065
587 MITRAL VALVE INCOMPETENCE 74 0.0065
588 GLOMERULAR FILTRATION RATE DECREASED 80 0.0065
589 URINARY RETENTION 217 0.0065
590 UPPER GASTROINTESTINAL HAEMORRHAGE 109 0.0065
591 COLD SWEAT 114 0.0065
592 DEPRESSION 1465 0.0064
593 TOOTH DISORDER 143 0.0064
594 DYSPHAGIA 610 0.0064
595 POLLAKIURIA 268 0.0064
596 BURNING SENSATION 449 0.0064
597 THERAPY CESSATION 328 0.0064
598 THINKING ABNORMAL 119 0.0064
599 OCULAR HYPERAEMIA 302 0.0064
600 LYMPHOMA 98 0.0063
601 HYPOAESTHESIA 949 0.0063
602 ARTHRALGIA 2632 0.0063
603 PAIN IN JAW 179 0.0063
604 GASTROENTERITIS 92 0.0063
605 ABDOMINAL DISTENSION 657 0.0063
606 GASTROINTESTINAL PAIN 69 0.0063
607 MALIGNANT MELANOMA 84 0.0063
608 SINUS TACHYCARDIA 89 0.0063
609 TOOTH FRACTURE 69 0.0063
610 BRAIN FOG 98 0.0062
611 PALLOR 170 0.0062
612 SYNCOPE 625 0.0062
613 MOBILITY DECREASED 448 0.0062
614 ANAL INCONTINENCE 56 0.0062
615 PRODUCT PRESCRIBING ERROR 148 0.0062
616 PSYCHOMOTOR HYPERACTIVITY 103 0.0062
617 ORTHOSTATIC HYPOTENSION 108 0.0062
618 RASH PRURITIC 336 0.0062
619 HOSPITALISATION 951 0.0062
620 FEELING COLD 172 0.0062
621 PHOTOPHOBIA 116 0.0062
622 EYE DISCHARGE 64 0.0062
623 LOSS OF CONSCIOUSNESS 787 0.0061
624 INITIAL INSOMNIA 63 0.0061
625 BONE PAIN 359 0.0061
626 INTESTINAL OBSTRUCTION 231 0.0061
627 INCORRECT DOSE ADMINISTERED 1396 0.0061
628 INFLUENZA LIKE ILLNESS 503 0.0061
629 HYPOAESTHESIA ORAL 92 0.0061
630 POLYNEUROPATHY 73 0.0061
631 BREAST PAIN 65 0.0061
632 SMALL INTESTINAL OBSTRUCTION 75 0.0061
633 GAIT INABILITY 203 0.0061
634 GENERAL PHYSICAL HEALTH DETERIORATION 701 0.0061
635 NODULE 79 0.0060
636 THERAPEUTIC RESPONSE DECREASED 367 0.0060
637 ANAPHYLACTIC SHOCK 156 0.0060
638 GALLBLADDER DISORDER 108 0.0060
639 NEOPLASM MALIGNANT 403 0.0060
640 RENAL PAIN 64 0.0060
641 WOUND INFECTION 66 0.0060
642 DIARRHOEA HAEMORRHAGIC 56 0.0060
643 THERAPEUTIC RESPONSE SHORTENED 198 0.0060
644 HEPATIC CIRRHOSIS 112 0.0060
645 FEELING HOT 364 0.0059
646 SKIN HAEMORRHAGE 88 0.0059
647 PRODUCT USE IN UNAPPROVED INDICATION 1467 0.0059
648 COLON CANCER 88 0.0059
649 VITREOUS FLOATERS 58 0.0059
650 PARAESTHESIA 928 0.0059
651 INJECTION SITE DISCOMFORT 62 0.0059
652 DYSSTASIA 172 0.0059
653 FLATULENCE 334 0.0059
654 MUSCULAR WEAKNESS 669 0.0059
655 DRUG PRESCRIBING ERROR 113 0.0059
656 PRURITUS GENERALISED 127 0.0059
657 STOMATITIS 356 0.0059
658 HYPOPHAGIA 150 0.0059
659 RENAL INJURY 174 0.0059
660 DEPRESSED MOOD 308 0.0058
661 HAEMATOCHEZIA 321 0.0058
662 COLITIS 220 0.0058
663 BALANCE DISORDER 500 0.0058
664 ULCER 92 0.0058
665 SCAR 99 0.0058
666 THROMBOSIS 465 0.0058
667 EATING DISORDER 123 0.0058
668 ANGIOEDEMA 254 0.0057
669 DIPLOPIA 149 0.0057
670 ABDOMINAL DISCOMFORT 960 0.0057
671 SPINAL PAIN 67 0.0057
672 MYOCARDIAL INFARCTION 994 0.0057
673 ACUTE MYOCARDIAL INFARCTION 168 0.0057
674 ABDOMINAL PAIN UPPER 1167 0.0057
675 DRUG EFFECT INCOMPLETE 205 0.0056
676 BASAL CELL CARCINOMA 88 0.0056
677 GASTROINTESTINAL HAEMORRHAGE 471 0.0056
678 PRODUCT ODOUR ABNORMAL 59 0.0056
679 BLOOD GLUCOSE ABNORMAL 104 0.0056
680 ABDOMINAL PAIN 1309 0.0056
681 PRODUCT AVAILABILITY ISSUE 128 0.0056
682 LOCAL SWELLING 98 0.0056
683 MUSCLE TIGHTNESS 91 0.0056
684 FEAR 151 0.0056
685 TREATMENT NONCOMPLIANCE 307 0.0056
686 BLOOD POTASSIUM INCREASED 91 0.0056
687 HAEMATOCRIT DECREASED 111 0.0056
688 SLUGGISHNESS 57 0.0056
689 WOUND 155 0.0055
690 INCONTINENCE 58 0.0055
691 PAIN 3370 0.0055
692 PNEUMONIA ASPIRATION 137 0.0055
693 HYPOKALAEMIA 253 0.0055
694 RASH MACULAR 191 0.0055
695 JOINT SWELLING 657 0.0054
696 IMPAIRED WORK ABILITY 116 0.0054
697 RASH ERYTHEMATOUS 259 0.0054
698 MOUTH ULCERATION 114 0.0054
699 DECREASED APPETITE 1256 0.0054
700 BEDRIDDEN 71 0.0054
701 TINNITUS 248 0.0054
702 PRURITUS 2071 0.0054
703 DISEASE RECURRENCE 256 0.0054
704 KNEE ARTHROPLASTY 113 0.0054
705 SKIN DISORDER 178 0.0053
706 ELECTROLYTE IMBALANCE 62 0.0053
707 MENTAL DISORDER 232 0.0053
708 INTRAOCULAR PRESSURE INCREASED 68 0.0053
709 EYE HAEMORRHAGE 71 0.0053
710 HYPERTHYROIDISM 77 0.0053
711 CHROMATURIA 120 0.0053
712 APHASIA 160 0.0053
713 MEDICATION ERROR 294 0.0053
714 UNDERDOSE 386 0.0053
715 VOMITING 2486 0.0053
716 HYPONATRAEMIA 297 0.0053
717 THERAPEUTIC RESPONSE UNEXPECTED 236 0.0053
718 DRUG INEFFECTIVE 6922 0.0052
719 DEHYDRATION 700 0.0052
720 SKIN FISSURES 102 0.0052
721 MUSCULOSKELETAL STIFFNESS 457 0.0052
722 ADVERSE EVENT 480 0.0052
723 CONSTIPATION 1135 0.0052
724 NEUROPATHY PERIPHERAL 494 0.0052
725 CONFUSIONAL STATE 838 0.0052
726 ANGER 174 0.0051
727 NAUSEA 4063 0.0051
728 GASTROINTESTINAL DISORDER 459 0.0051
729 PRODUCT DISPENSING ERROR 111 0.0051
730 HIP ARTHROPLASTY 78 0.0051
731 CEREBROVASCULAR ACCIDENT 859 0.0051
732 TUBULOINTERSTITIAL NEPHRITIS 95 0.0051
733 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56 0.0051
734 MUSCLE ATROPHY 64 0.0050
735 HYPERHIDROSIS 650 0.0050
736 EXTRA DOSE ADMINISTERED 204 0.0050
737 SPINAL OPERATION 62 0.0050
738 INTERNATIONAL NORMALISED RATIO INCREASED 143 0.0050
739 PRODUCT PHYSICAL ISSUE 101 0.0050
740 C-REACTIVE PROTEIN INCREASED 182 0.0050
741 ADVERSE DRUG REACTION 449 0.0050
742 DIARRHOEA 3218 0.0050
743 INCORRECT ROUTE OF DRUG ADMINISTRATION 178 0.0050
744 ABASIA 123 0.0050
745 RASH 2170 0.0050
746 PERIPHERAL COLDNESS 68 0.0049
747 IMPAIRED DRIVING ABILITY 56 0.0049
748 HYPOTENSION 985 0.0049
749 MOOD SWINGS 156 0.0049
750 HAEMATURIA 167 0.0049
751 CRYING 177 0.0049
752 DRUG EFFECT DECREASED 262 0.0049
753 EXPIRED PRODUCT ADMINISTERED 161 0.0048
754 MENTAL IMPAIRMENT 117 0.0048
755 SURGERY 282 0.0048
756 CARDIOMYOPATHY 71 0.0048
757 HOT FLUSH 362 0.0048
758 DISTURBANCE IN ATTENTION 259 0.0048
759 LIVER FUNCTION TEST INCREASED 103 0.0048
760 LETHARGY 276 0.0048
761 ANHEDONIA 126 0.0048
762 ANAEMIA 914 0.0048
763 PHOTOSENSITIVITY REACTION 79 0.0048
764 HAEMATEMESIS 121 0.0048
765 MELAENA 105 0.0048
766 SEPSIS 531 0.0048
767 PROCEDURAL PAIN 132 0.0048
768 SKIN ULCER 123 0.0048
769 SOMNOLENCE 956 0.0047
770 DISORIENTATION 188 0.0047
771 HUNGER 66 0.0047
772 GASTRIC ULCER 90 0.0047
773 JOINT STIFFNESS 124 0.0047
774 THERAPEUTIC PRODUCT EFFECT DECREASED 211 0.0047
775 TACHYPNOEA 64 0.0047
776 FREQUENT BOWEL MOVEMENTS 127 0.0047
777 PARANOIA 81 0.0047
778 ARTHROPATHY 261 0.0047
779 ECONOMIC PROBLEM 71 0.0047
780 AGITATION 344 0.0047
781 ERYTHEMA 959 0.0047
782 HAEMOGLOBIN DECREASED 478 0.0047
783 HYPERKALAEMIA 163 0.0046
784 LEUKOCYTOSIS 84 0.0046
785 PRODUCT USE COMPLAINT 73 0.0046
786 IMPAIRED HEALING 151 0.0046
787 HYPOMAGNESAEMIA 64 0.0046
788 TOOTH EXTRACTION 57 0.0046
789 MOVEMENT DISORDER 147 0.0046
790 DIABETES MELLITUS INADEQUATE CONTROL 81 0.0046
791 AGRANULOCYTOSIS 85 0.0046
792 MUSCULOSKELETAL DISORDER 87 0.0046
793 DEEP VEIN THROMBOSIS 296 0.0046
794 EYE IRRITATION 262 0.0045
795 JOINT RANGE OF MOTION DECREASED 61 0.0045
796 INJECTION SITE PRURITUS 304 0.0045
797 MUSCLE TWITCHING 104 0.0045
798 RESTLESSNESS 165 0.0045
799 INTERSTITIAL LUNG DISEASE 218 0.0045
800 DRUG ADMINISTRATION ERROR 138 0.0045
801 FRACTURE 85 0.0045
802 PARALYSIS 64 0.0045
803 FULL BLOOD COUNT DECREASED 90 0.0045
804 DEATH 3844 0.0045
805 RED BLOOD CELL COUNT DECREASED 127 0.0044
806 TOOTH LOSS 92 0.0044
807 ANKYLOSING SPONDYLITIS 58 0.0044
808 HYPERGLYCAEMIA 160 0.0044
809 DERMATITIS 92 0.0044
810 HYPOCALCAEMIA 83 0.0044
811 INFUSION RELATED REACTION 289 0.0044
812 RHEUMATOID ARTHRITIS 495 0.0044
813 ABNORMAL DREAMS 120 0.0043
814 INCREASED APPETITE 83 0.0043
815 IRRITABILITY 261 0.0043
816 EXPOSURE VIA SKIN CONTACT 112 0.0043
817 RENAL IMPAIRMENT 363 0.0043
818 HEPATOCELLULAR INJURY 61 0.0043
819 LYMPHOCYTE COUNT DECREASED 76 0.0043
820 SENSORY DISTURBANCE 69 0.0043
821 DISABILITY 85 0.0043
822 BLINDNESS 175 0.0043
823 PRESCRIBED OVERDOSE 83 0.0043
824 CIRCULATORY COLLAPSE 73 0.0043
825 INJURY ASSOCIATED WITH DEVICE 87 0.0043
826 PANCREATITIS ACUTE 96 0.0043
827 INJECTION SITE RASH 131 0.0043
828 HAEMORRHAGE 446 0.0043
829 SKIN DISCOLOURATION 196 0.0043
830 DEVICE USE ERROR 148 0.0043
831 FLUSHING 432 0.0042
832 DERMATITIS ATOPIC 223 0.0042
833 DEVICE RELATED INFECTION 65 0.0042
834 PRODUCT COMPLAINT 107 0.0042
835 RASH GENERALISED 109 0.0042
836 ERUCTATION 81 0.0042
837 BLOOD UREA INCREASED 70 0.0042
838 BLISTER 234 0.0042
839 SKIN CANCER 89 0.0041
840 COLITIS ULCERATIVE 184 0.0041
841 SUICIDAL IDEATION 376 0.0041
842 UNRESPONSIVE TO STIMULI 106 0.0041
843 ISCHAEMIC STROKE 73 0.0041
844 OSTEOMYELITIS 74 0.0041
845 TRANSAMINASES INCREASED 90 0.0040
846 CARDIAC ARREST 330 0.0040
847 SKIN EXFOLIATION 334 0.0040
848 PRODUCT PRESCRIBING ISSUE 86 0.0039
849 ALOPECIA 769 0.0039
850 INJECTION SITE BRUISING 312 0.0039
851 BLOOD ALKALINE PHOSPHATASE INCREASED 97 0.0039
852 BLOOD CREATININE INCREASED 254 0.0039
853 DYSARTHRIA 146 0.0039
854 UNEVALUABLE EVENT 293 0.0039
855 COMPLICATION ASSOCIATED WITH DEVICE 56 0.0039
856 RESPIRATORY ARREST 106 0.0038
857 DEVICE BREAKAGE 156 0.0038
858 COAGULOPATHY 64 0.0038
859 COGNITIVE DISORDER 179 0.0038
860 PANCREATITIS 202 0.0038
861 HALLUCINATION 288 0.0038
862 MOOD ALTERED 104 0.0038
863 SEIZURE 440 0.0038
864 GLYCOSYLATED HAEMOGLOBIN INCREASED 96 0.0038
865 EXPOSURE DURING PREGNANCY 236 0.0038
866 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 270 0.0038
867 LIVER DISORDER 167 0.0038
868 DEVICE LEAKAGE 163 0.0038
869 ELECTROCARDIOGRAM QT PROLONGED 135 0.0037
870 DRUG INTOLERANCE 362 0.0037
871 GENERALISED TONIC-CLONIC SEIZURE 62 0.0037
872 DRUG LEVEL INCREASED 62 0.0037
873 INJECTION SITE SWELLING 286 0.0037
874 ABDOMINAL PAIN LOWER 94 0.0037
875 HYPOGLYCAEMIA 178 0.0037
876 INJECTION SITE URTICARIA 90 0.0037
877 DRUG ERUPTION 65 0.0037
878 DRUG INTERACTION 578 0.0036
879 HEPATIC ENZYME INCREASED 248 0.0036
880 BRADYCARDIA 192 0.0036
881 THERAPY INTERRUPTED 258 0.0036
882 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
883 MANIA 59 0.0036
884 DRY SKIN 477 0.0036
885 BLOOD GLUCOSE DECREASED 171 0.0036
886 RASH MACULO-PAPULAR 79 0.0035
887 COMA 169 0.0035
888 BONE DENSITY DECREASED 111 0.0035
889 ASCITES 104 0.0035
890 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 60 0.0035
891 HALLUCINATION, VISUAL 73 0.0035
892 EMOTIONAL DISORDER 106 0.0034
893 RASH PAPULAR 77 0.0034
894 GAMMA-GLUTAMYLTRANSFERASE INCREASED 76 0.0034
895 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
896 DELIRIUM 117 0.0034
897 BLOOD CREATINE PHOSPHOKINASE INCREASED 97 0.0034
898 DYSKINESIA 135 0.0033
899 WRONG TECHNIQUE IN DRUG USAGE PROCESS 120 0.0033
900 ABNORMAL BEHAVIOUR 130 0.0033
901 INJECTION SITE MASS 121 0.0033
902 INJECTION SITE PAIN 993 0.0032
903 LIVER FUNCTION TEST ABNORMAL 94 0.0032
904 HEPATITIS 82 0.0032
905 EMOTIONAL DISTRESS 387 0.0032
906 PELVIC PAIN 58 0.0032
907 THERAPY NON-RESPONDER 143 0.0032
908 AGGRESSION 159 0.0032
909 OSTEONECROSIS 104 0.0032
910 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
911 PSORIASIS 409 0.0031
912 SEPTIC SHOCK 136 0.0031
913 MATERNAL EXPOSURE DURING PREGNANCY 277 0.0031
914 FEMUR FRACTURE 96 0.0031
915 RHABDOMYOLYSIS 129 0.0031
916 INJURY 216 0.0031
917 ENCEPHALOPATHY 75 0.0031
918 INJECTION SITE ERYTHEMA 376 0.0030
919 ALANINE AMINOTRANSFERASE INCREASED 186 0.0030
920 LACTIC ACIDOSIS 98 0.0030
921 ERECTILE DYSFUNCTION 77 0.0030
922 CEREBRAL HAEMORRHAGE 107 0.0030
923 NEEDLE ISSUE 86 0.0030
924 PROTEINURIA 56 0.0029
925 JAUNDICE 79 0.0029
926 BLOOD BILIRUBIN INCREASED 79 0.0029
927 CARDIOVASCULAR DISORDER 74 0.0029
928 PLATELET COUNT DECREASED 309 0.0029
929 PANCYTOPENIA 162 0.0029
930 BLOOD GLUCOSE INCREASED 545 0.0029
931 PRODUCT SUBSTITUTION ISSUE 166 0.0029
932 PSORIATIC ARTHROPATHY 117 0.0029
933 METABOLIC ACIDOSIS 92 0.0029
934 LABORATORY TEST ABNORMAL 84 0.0028
935 BREAST CANCER FEMALE 75 0.0028
936 OSTEONECROSIS OF JAW 69 0.0028
937 RENAL FAILURE ACUTE 118 0.0028
938 WITHDRAWAL SYNDROME 116 0.0028
939 INJECTION SITE REACTION 190 0.0028
940 SKIN IRRITATION 125 0.0027
941 CARDIO-RESPIRATORY ARREST 114 0.0027
942 NERVOUS SYSTEM DISORDER 85 0.0027
943 EPILEPSY 83 0.0027
944 PAIN OF SKIN 73 0.0027
945 SHOCK 62 0.0027
946 CONTRAINDICATED PRODUCT ADMINISTERED 81 0.0027
947 PSYCHOTIC DISORDER 79 0.0027
948 NO ADVERSE EVENT 478 0.0026
949 ASPARTATE AMINOTRANSFERASE INCREASED 139 0.0026
950 STEVENS-JOHNSON SYNDROME 58 0.0026
951 HEPATIC FUNCTION ABNORMAL 95 0.0025
952 THROMBOCYTOPENIA 284 0.0025
953 ABORTION SPONTANEOUS 100 0.0025
954 MENTAL STATUS CHANGES 69 0.0025
955 CONVULSION 141 0.0025
956 ACCIDENTAL OVERDOSE 89 0.0024
957 FEBRILE NEUTROPENIA 161 0.0024
958 BREAST CANCER 226 0.0024
959 WHITE BLOOD CELL COUNT DECREASED 256 0.0024
960 ACNE 179 0.0024
961 HEPATIC FAILURE 71 0.0024
962 VAGINAL HAEMORRHAGE 100 0.0023
963 OVERDOSE 482 0.0022
964 SUICIDE ATTEMPT 134 0.0022
965 PLASMA CELL MYELOMA 84 0.0022
966 INJECTION SITE HAEMORRHAGE 170 0.0021
967 DISEASE PROGRESSION 248 0.0021
968 MULTIPLE SCLEROSIS 100 0.0021
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 114 0.0021
970 DEPRESSED LEVEL OF CONSCIOUSNESS 82 0.0021
971 NEUTROPHIL COUNT DECREASED 84 0.0021
972 LEUKOPENIA 99 0.0020
973 PRODUCT STORAGE ERROR 168 0.0019
974 DRUG-INDUCED LIVER INJURY 60 0.0019
975 ACCIDENTAL EXPOSURE TO PRODUCT 189 0.0018
976 MALIGNANT NEOPLASM PROGRESSION 182 0.0018
977 NEUTROPENIA 239 0.0018
978 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
979 FOETAL EXPOSURE DURING PREGNANCY 138 0.0017
980 SKIN BURNING SENSATION 121 0.0017
981 NEOPLASM PROGRESSION 57 0.0016
982 MULTIPLE SCLEROSIS RELAPSE 109 0.0016
983 PROSTATE CANCER 123 0.0015
984 TREATMENT FAILURE 120 0.0014
985 DEVICE DISLOCATION 62 0.0014
986 DRUG DEPENDENCE 206 0.0013
987 DEVICE DIFFICULT TO USE 79 0.0012
988 DRUG WITHDRAWAL SYNDROME 98 0.0011
989 INTENTIONAL OVERDOSE 64 0.0010
990 TOXICITY TO VARIOUS AGENTS 162 0.0010
991 DRUG ABUSE 66 0.0008